Diagnostic of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis
Key facts
- Who runs it
- University Hospital, Toulouse
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 185 people, planned
- Started
- 12 Feb 2025
- Expected to end
- Feb 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- CSF sample
- Record updated
- 31 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age ⩾ 18 years
- Patient with an external ventriculostomy implanted at the Toulouse University Hospital
- Patient suspected of nosocomial meningitis due to a febrile syndrome (in the absence of any other identified infectious site), headache, nausea, lethargy, change in neurological status, meningeal syndrome, epileptic event and cutaneous or subcutaneous inflammation at the ventriculostomy site of insertion
- Patient having expressed oral consent, after free and informed information
- Patient affiliated to a social security scheme
Who cannot take part
- Proven or suspected meningitis and/or ventriculitis during the previous month
- Diagnosis of nosocomial meningitis made in another medical centre prior to admission
- Short bowel syndrome
- End-stage renal failure (GFR < 15 ml/min/m2)
- Diagnosis of community meningitis
- Acute mesenteric ischaemia
- Peritoneal dialysis
- Patient participating in another research protocol with an exclusion period still in progress
- Pregnant or breastfeeding woman
- Patient under guardianship or trusteeship, persons placed under the protection of justice
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The TOTEM study is a single-center study designed to evaluate the performance of the D-lactate assay in cerebrospinal fluid (CSF) for the diagnosis of ventriculostomy-related nosocomial meningitis. The study will be conducted in the neurosurgical intensive care unit of the Toulouse University Hospital, in patients with a suspected diagnosis of ventriculostomy-related nosocomial meningitis.
The 2 groups in the trial
- Ventriculostomy-related nosocomial meningitisTreatment being tested
Finally, two neurosurgical reanimators will retrospectively diagnose nosocomial meningitis, or the absence of meningitis, according to the information from the patient's medical records.
Treatment: CSF sample
- Absence of nosocomial meningitisOther group
Finally, two neurosurgical reanimators will retrospectively diagnose nosocomial meningitis, or the absence of meningitis, according to the information from the patient's medical records.
Treatment: CSF sample
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Diagnostic Significance of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis : a Pilot Study
- Record updated
- 31 December 2025